- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01666561
The Effect of Oat Based Breakfast Cereals on Satiety and Food Intake. (Quaker A)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- 18 years of age or older and are healthy.
- Taking no regular medications other than birth control or hormone replacement therapy.
- Are willing to use an effective method of birth control if you are capable of bearing children. Acceptable methods include abstinence, barrier methods, intrauterine devices, and hormonal methods of contraception.
Exclusion Criteria:
- Are a woman who is pregnant or nursing a baby.
- Have gained or lost 8.8 pounds or more in the last 3 months.
- Have diabetes or a fasting blood sugar over 126 mg/dL.
- Have a score of 14 or greater on the restraint scale of the 3-factor eating questionnaire (a questionnaire which will be given to you by the study staff).
- Are allergic to oats, lactose-free milk, Honey Nut Cheerios or oatmeal.
Study Plan
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Breakfast Test Cereal 1, Oat based
Test cereal 1, Oat based breakfast cereal- you will be randomly presented with a breakfast consisting of either: Oat-based breakfast cereal with lactose-free, fat-free milk to drink or ready-to-eat cereal in lactose-free, fat -free milk with water to drink. Then you will complete a visual analog scale at 30, 60, 120. 180, and 240 minutes following the start of breakfast meal. |
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (a) one serving of oat based breakfast cereal 1.
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (b) an equicaloric amount of Oat based breakfast cereal 2.
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (c) an equicaloric amount of the ready-to-eat cold cereal.
|
Experimental: Breakfast Test Cereal 2, Oat-based
Test Cereal 2, Oat-based breakfast cereal. You will be randomly presented with a breakfast consisting of either: Oat-based breakfast cereal with lactose-free, fat-free milk to drink or ready-to-eat oat brand cereal in lactose-free, fat -free milk with water to drink. Then you will complete a visual analog scale at 30, 60, 120. 180, and 240 minutes following the start of breakfast meal. |
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (a) one serving of oat based breakfast cereal 1.
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (b) an equicaloric amount of Oat based breakfast cereal 2.
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (c) an equicaloric amount of the ready-to-eat cold cereal.
|
Experimental: Ready-to-eat cereal
Ready-to-eat cereal, Oat based breakfast cereal- you will be randomly presented with a breakfast consisting of either: one Oat-based breakfast cereal with lactose-free, fat-free milk to drink or ready-to-eat cereal in lactose-free, fat -free milk with water to drink. Then you will complete a visual analog scale at 30, 60, 120. 180, and 240 minutes following the start of breakfast meal. |
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (a) one serving of oat based breakfast cereal 1.
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (b) an equicaloric amount of Oat based breakfast cereal 2.
The study design is a crossover trial with each subject receiving one of the cereals in each of three visits separated by at least a week will be enrolled to investigate the satiety impact of three breakfast cereals: (c) an equicaloric amount of the ready-to-eat cold cereal.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Satiety Impact
Time Frame: up to day 3
|
Breakfast containing of oat-based breakfast cereal will cause people to feel more satiated compared to a breakfast containing of ready-to-eat oat-based breakfast cereal.
Appetite and satiety will be measured with a Visual Analog Scale.
|
up to day 3
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- PBRC 12029 (Period 1)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Food Intake
-
Pennington Biomedical Research CenterActive, not recruitingFood Intake | Energy Intake | Dietary Assessment | Food PhotographyUnited States
-
Clinical Nutrition Research Centre, SingaporeCompletedMarkedly Reduced Food Intake | Satiety and Food IntakeSingapore
-
Stanford UniversityCompletedAvoidant / Restrictive Food Intake Disorder
-
Tilburg UniversityCompleted
-
Pennington Biomedical Research CenterCompellis PharmaceuticalsTerminated
-
Oxford Brookes UniversityCompleted
-
Claudine MANACHNational Research Agency, FranceCompletedBiomarkers | Food IntakeFrance
-
Ryerson UniversityThe Hershey CompanyCompletedFood Intake | SatietyCanada
-
Massachusetts General HospitalAmerican Psychological Foundation; The Hilda & Preston Davis FoundationCompletedAvoidant/Restrictive Food Intake Disorder (ARFID)United States
-
Massachusetts General HospitalRecruitingAvoidant/Restrictive Food Intake Disorder (ARFID)United States
Clinical Trials on Breakfast Test Cereal 1, Oat based
-
Pennington Biomedical Research CenterPepsiCo Global R&D; Quaker Oats CompanyCompletedFood Intake | SatietyUnited States
-
Mondelēz International, Inc.Glycemic Index Laboratories, IncCompleted
-
Ziekenhuis Oost-LimburgCompletedAngina, Stable | Angina Pectoris | Angina, Unstable | Non STEMI | Angina, Prinzmetal'sBelgium
-
Westlake UniversityHangzhou Third People's HospitalRecruiting
-
University of TorontoDairy Farmers of CanadaCompletedObesity | DiabetesCanada
-
Danone ResearchCompletedHealthy Free-living ElderlyBelgium
-
Danone ResearchCompletedHealthy Adult WomenUnited States
-
Danone ResearchCompletedHealthy Adult WomenFrance
-
Catholic Relief ServicesCenters for Disease Control and PreventionCompleted
-
University of California, San DiegoLeadiant Biosciences, Inc.TerminatedAcute Lymphocytic Leukemia | Adult Lymphoblastic LymphomaUnited States